Early experience with intravitreal bevacizumab combined with laser treatment for retinopathy of prematurity
{{output}}
Objective: This study was designed to present our early experience with intravitreal bevacizumab combined with laser treatment for retinopathy of prematurity (ROP) at a single institution over a 13-month-period. ... ...
